Skip to content
Open access

Harnessing cell cycle synchronization to boost the therapeutic potential of umbilical cord MSCs against acute colitis

Oct 2026 · Scientific Reports · 0 citations

TL;DR

Compared with non-synchronized UCMSCs, synchronization associated with pretreatment of UCMSCs significantly attenuated DSS-induced colon shortening, promoted histological restoration, and reduced inflammatory cell infiltration in acute colitis.

Abstract

Human umbilical cord mesenchymal stromal cells (UCMSCs) are multipotent stem cells with strong immunomodulatory capacity, ease of acquisition, low immunogenicity, and a non-tumorigenic nature, making them attractive candidates for tissue repair. Under standard culture conditions, cells within a population exist in various cell cycle phases. Considering the inherent rhythmicity in biological systems, we hypothesize that synchronizing the cell cycle of UCMSCs could enhance their therapeutic efficacy for specific diseases. Serum starvation was used to synchronize UCMSCs in the G0/G1 phase. The starvation-double thymidine block method was employed to achieve S-phase synchronization. Subsequently, S-phase-synchronized cells were cultured in complete medium to induce progression into the G2/M phase. We evaluated the biological characteristics of UCMSCs across these phases, including senescence, apoptosis, proliferation potential, factor secretion, and immunoregulatory capacity. An acute colitis mouse model was established using 5% dextran sulfate sodium (DSS) solution. On the first day and fifth day respectively, UCMSCs synchronized to different cell cycle phases were administered via tail vein and intraperitoneal injection. Disease Activity Index (DAI) was scored daily. On day 7, colon length was measured, and colon tissues were analyzed via H&E, PAS, and MPO staining to assess histopathology and inflammatory infiltration. The proportion of regulatory T cells (Tregs) in peripheral blood, spleen, and mesenteric lymph nodes was also measured. Serum starvation synchronized approximately 80–90% of UCMSCs to the G0/G1 phase. The starvation-double thymidine block method synchronized about 60% of cells to the S phase. Culturing S-phase-synchronized cells in complete medium for 4–8 h yielded approximately 40% enrichment to the G2/M phase. Cell cycle synchronization did not significantly affect senescence or apoptosis. G0/G1-phase cells exhibited the lowest proliferation potential, whereas S-phase and G2/M-phase cells showed increased potential. S-phase cells secreted less TGF-β, while PGE2 secretion showed an increasing trend across G0/G1, S, and G2/M phases. Synchronization-associated UCMSCs did not significantly regulate Th1/Th17 cells but demonstrated a modulatory effect on Tregs. Compared with non-synchronized UCMSCs, synchronization associated with pretreatment of UCMSCs significantly attenuated DSS-induced colon shortening, promoted histological restoration, and reduced inflammatory cell infiltration in acute colitis. Cell cycle synchronization, rather than a specific cell cycle phase, enhances the therapeutic efficacy of UCMSCs in acute colitis. This study proposes a pretreatment strategy related to UCMSCs synchronization to optimize treatment outcomes for acute colitis.

Read PDF

Similar papers

Open access Oct 2026

Animal-origin-free medium enhances G2/M progression while maintaining identity and genomic stability in human adipose-derived MSCs

Mesenchymal stem cells (MSCs) are considered promising candidates for regenerative and immunomodulatory therapies. However, their clinical use requires xeno-free, good manufacturing practice (GMP)-compatible culture systems. Conventional serum-containing media (FCM) present variability and xenogeneic risk; as such, ser...

Su-Jin Lee, Chunggeon Lee, Eunji Kim et al. · 0 citations
Oct 2026

The secretome of UC-MSC reprogrammed to a glycolytic metabolism promotes Treg generation and naive CD4 T cells stability in PBMC from rheumatoid arthritis patients.

OBJECTIVE Rheumatoid arthritis (RA) is characterized by persistent inflammation and dysregulated T cell responses. Mesenchymal stromal cells (MSCs) have immunomodulatory properties, but their clinical efficacy remains variable. We investigated whether metabolic reprogramming of umbilical cord-derived MSCs (UC-MSCs) tow...

N. Luque-Campos, C. Pradenas, E. Lara-Barba et al. · 0 citations
Review Oct 2026

Extending the Lifespan of Human Mesenchymal Stromal Cells: Approaches to Immortalization and Clinical Prospects.

Mesenchymal stromal cells (MSCs) have a limited proliferative lifespan associated with replicative senescence, although the extent and onset of replicative senescence may vary among MSC sources. The immortalization of MSCs is being investigated as a strategy to extend proliferative capacity and facilitate scale-up. Mor...

S. Krishna, Nikshitha Kulal, S. Kannan et al. · 0 citations
Open access Oct 2026

hiPSC Extract Attenuates Senescence-Associated Phenotypes in AB-MSCs In Vitro

Background: Bone marrow mesenchymal stromal cells (BMSCs) are widely used as seed cells in bone tissue engineering. However, sufficient cell quantities for effective engineering typically require prolonged in vitro expansion of BMSCs, which can lead to cellular senescence after excessive subculturing. Objective: This s...

Yuan-Yuan Pan, Lu-Miao Zhang, Rong-Yuan Zhu et al. · 0 citations
Open access Sep 2026

Effects of Hypoxia and Lipopolysaccharide on the Migration Capacity and Paracrine Factor Expression of Human Umbilical Cord Mesenchymal Stem Cells

It is indicated that the combination of hypoxia and LPS treatment affects the proliferative capacity of UC-MSCs, thus enhancing the MSC migration rate, and hypoxia and LPS together reduce the expression of paracrine factors in UC-MSCs, potentially attenuating the immunomodulatory efficacy of UC-MSCs in tissue injury mi...

Arfianti Arfianti, Vitriyanna Mutiara Yuhendri, Fadhilla Maulany El Fajri et al. · 0 citations
Open access Sep 2026

Metabolic profiling of licensed mesenchymal stromal cells reveals a disconnect between glycolytic fitness and immunomodulatory responsiveness

Mesenchymal stromal cells (MSCs) are promising cell therapeutics, but their development as off-the-shelf products requires cryopreservation, which impairs cell function after thaw. Inflammatory licensing enhances MSC therapeutic attributes, yet protocols vary considerably and little is known about how these variables a...

H. Bilal, B. DeGroot, L. Braid · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.